Recreational Marijuana Laws Did Not Increase Substance Use Among Adolescents
Drug Topics
APRIL 24, 2024
With more states allowing the use of recreational marijuana than ever before, researchers examined its effects among youth populations.
Wed.Apr 24, 2024
203 
Advocate for Greater Pharmacy Technician Roles
Pharmacy Times
APRIL 24, 2024
Multiple state and federal laws since the COVID-19 pandemic highlight the growing role of technicians
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
In Depth Perspectives: Psychedelic Medicine, Scope Creep, And More
Drug Topics
APRIL 24, 2024
Check out these top featured stories from Drug Topics in April 2024.
Massive amounts of H5N1 vaccine would be needed if there’s a bird flu pandemic. Can we make enough?
STAT
APRIL 24, 2024
The unsettling reality of H5N1 bird flu circulating in dairy cow herds in multiple parts of the United States is raising anxiety levels about whether this dangerous virus, which has haunted the sleep of people who worry about influenza pandemics for more than 20 years, could be on a path to acquiring the ability to easily infect people. To be clear, there is no evidence that this is currently the case — the sole confirmed human case reported in Texas three weeks ago was in a farm worker w
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Influenza Vaccines: Is the Quality of Evidence the Same?
Drug Topics
APRIL 24, 2024
In response to historically low flu vaccine coverage rates, Kristen Thorson, PharmD, urges pharmacists to think back to their pandemic immunization efforts and “know the power of their recommendation,” to boost public protection from influenza.
USDA orders H5N1 testing of some dairy cows to limit spread of bird flu
STAT
APRIL 24, 2024
The U.S. Department of Agriculture moved to try to limit spread of the H5N1 bird flu virus among dairy cattle on Wednesday, issuing a federal order that will require an animal to test negative for the virus before it can be moved across state lines. It also requires laboratories and state veterinarians to report to the USDA any animals that have tested positive for H5N1 or any other influenza A virus.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Decline in heart failure deaths has been undone, led by people under 45
STAT
APRIL 24, 2024
Heart failure mortality rates are moving in the wrong direction, a new analysis reports, reversing a decline in deaths that means more people in the United States are dying of the condition today than 25 years ago. The concerning conclusion comes as newer medications are raising hopes for better outcomes in the years to come. A research letter published Wednesday in JAMA Cardiology tracked U.S. death certificate data from 1999 through 2021, revealing a steady drop in deaths until 2012, when rate
Walgreens expands specialty pharmacy business to gene and cell therapy services
Fierce Healthcare
APRIL 24, 2024
Walgreens is expanding its specialty pharmacy services to offer gene and cell therapy services, supported by a dedicated 18,000-square-foot center in Pittsburgh, the company announced Thursday. | Walgreens is expanding its specialty pharmacy services to offer gene and cell therapy services, supported by a dedicated 18,000-square-foot center in Pittsburgh, the company announced Thursday.
Opinion: Balancing hope and reality: The promise and peril of blood-based colorectal cancer screening
STAT
APRIL 24, 2024
As a gastroenterologist and cancer researcher, my mission is to help my patients live longer, healthier, and cancer-free lives. A rise in the number of younger Americans diagnosed with colorectal cancer worries me — early-age onset colorectal cancer is expected to surge by more than 140% by 2030. But because colorectal cancer is preventable with early screening and detection, it’s possible to reduce the number of Americans diagnosed with this disease in the prime of their lives.
Recombinant Zoster Vaccine Demonstrates High Protection Against Shingles in Adult Patients
Pharmacy Times
APRIL 24, 2024
The recombinant zoster vaccine demonstrated a 79.7% efficacy in patients aged 50 years and older cumulatively within the 6- to 11-year period after vaccination.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: New studies suggest GLP-1 health care costs have only begun to climb
STAT
APRIL 24, 2024
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they’re set to cost the U.S. health care system and the federal government still more this year and beyond, two new reports released Wednesday show. One study from the American Society of Health-System Pharmacists found that GLP-1 treatments were a main driver of the increase in overall drug spending by health entities such as pharmacies and hospitals last year.
Optimizing Oncological Care: The Influence of AI on Insurance Approvals
Pharmacy Times
APRIL 24, 2024
Successful integration demands overcoming various hurdles.
STAT+: HCA to expand the use of AI tool to automate clinical documentation in ER
STAT
APRIL 24, 2024
HCA Healthcare, the largest for-profit hospital chain in the United States, is planning to expand the use of an artificial intelligence tool to document doctor-patient interactions in its emergency rooms. The plans for a broader roll out of the AI tool across its network comes nearly a year after the 184-hospital health system started working with medical documentation company Augmedix to pilot its ambient scribe technology at a handful of ER departments within the HCA network.
Accurate, Complete Data Entry Is Key to Medication Safety
Pharmacy Times
APRIL 24, 2024
Carefully checking every piece of information and proofreading for accuracy is crucial to ensure patient safety
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: Equity, technology, and costs top of mind for life science’s leaders
STAT
APRIL 24, 2024
Physicians, researchers, CEOs, reporters, and more gathered in downtown Boston Wednesday night to celebrate STAT’s 2024 STATUS List , which features 50 leaders in the life sciences. Members of this year’s list (and a few past honorees) spoke about what issues in their fields — ranging from investment to clinical research to bedside treatment — need to be prioritized in order to improve health care across the U.S. and the rest of the world.
Pfizer and BioNTech commence legal action against Moderna in UK court
Pharmaceutical Technology
APRIL 24, 2024
Pfizer and its Germany partner BioNTech have urged London’s High Court to invalidate competitor Moderna's patents over technology instrumental in the Covid-19 vaccines development as the latest phase of a global legal fight that started yesterday (23 April), reported Reuters.
Chocolate milk will stay on school lunch menus, as USDA reverses course
STAT
APRIL 24, 2024
WASHINGTON – Chocolate milk in schools is here to stay. The Department of Agriculture announced Wednesday that it has abandoned a previous proposal to restrict the sale of flavored milk in elementary and middle schools. Instead, the USDA will enforce a limit on added sugars in flavored milk starting in the fall of 2025.
FDA initiative puts AR/VR at heart of home health drive
pharmaphorum
APRIL 24, 2024
A new FDA initiative is seeing how augmented reality and virtual reality (AR/VR) can make patients’ own homes an integral part of the healthcare system
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Colombia issues a compulsory license for an HIV medicine and ‘plants a flag for global health equity’
STAT
APRIL 24, 2024
After months of deliberation, the Colombian government has issued a compulsory license for an HIV medicine, the first time the country has taken such a step, one that also marks a significant move in the increasingly global battle over access to medicines. The license is designed so that tens of thousands of Colombians can obtain a lower-cost version of dolutegravir, a medicine that is manufactured and sold by ViiV Healthcare, a company that specializes in HIV treatments and is largely controlle
Roche's Vabysmo shows no sign of slowdown after Regeneron and Bayer's launch of Eylea HD
Fierce Pharma
APRIL 24, 2024
It’s been eight months since Regeneron secured approval for a high-dose version of its powerhouse macular degeneration treatment Eylea in the U.S. | How much impact has the approval of high-dose Eylea had on the upward trajectory of Roche’s Vabysmo? Not much, according to sales figures released by Roche.
STAT+: Biosimilars haven’t always yielded lower out-of-pocket costs for patients, study finds
STAT
APRIL 24, 2024
Two years after biosimilars became available in the U.S., a higher proportion of patients using brand-name biologics were paying out-of-pocket costs, which were also, on average, 12% higher than before, according to a recent study. In addition, patients who used biosimilars often did not pay lower out-of-pocket costs than those who were given brand-name biologic medicines.
Developing Novel Treatments for Schizophrenia: Opportunities and Challenges in Personalizing Care
Pharmacy Times
APRIL 24, 2024
Exploring challenges and opportunities in developing personalized treatments for schizophrenia
Watch: What we know about traces of H5N1 bird flu found in pasteurized milk
STAT
APRIL 24, 2024
Genetic evidence of the H5N1 bird flu virus was found in grocery store milk in the United States this week, according to the Food and Drug Administration. The news follows the discovery that the avian flu has been detected in dairy cows. But what do traces of virus in pasteurized milk mean for consumers? In this video, STAT explains what is known about the safety of milk on grocery shelves.
Emergence of ADCs as the “hot, new technology”
pharmaphorum
APRIL 24, 2024
Explore the emergence of ADCs as the "hot, new technology" in the biopharmaceutical industry with companies like ImmunoGen, acquisitioned by AbbVie leading the way. Understand the potential of antibody-drug conjugates and their impact on innovative therapies.
STAT+: Biogen’s Alzheimer’s drug launch on ‘steady pace’ as logistical hurdles recede
STAT
APRIL 24, 2024
Biogen on Wednesday reported first-quarter earnings that beat Wall Street expectations largely on reduced expenses. Total revenue was slightly weak overall, but sales were stronger for two newly launched medicines — Leqembi and Skyclarys — that matter most to the biotech’s turnaround effort. Shares rose 5% to $202 in early trading.
Embracing a new future-ready pharmacovigilance ecosystem
pharmaphorum
APRIL 24, 2024
Explore the concept of embracing a future-ready pharmacovigilance ecosystem and discover how advancements in technology and regulations are shaping the future of drug safety monitoring.
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
Fierce Healthcare
APRIL 24, 2024
The Food & Drug Administration’s device center launched an initiative to promote at-home medical device development with a focus on health equity in at-home care. | Medical devices and other innovations that make acute and on-going at-home clinical management possible are receiving a boost in attention from FDA. The agency will use virtual reality to simulate patients' home environments for developers and policymakers.
STAT+: A spending frenzy on obesity drugs
STAT
APRIL 24, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today we have some developments about Novo Nordisk’s insulin business, a side of the company that people don’t really talk about anymore, and some news about their GLP-1 business, a side that people can’t stop talking about.
Independent Pharmacies Must Look Out For Deceptive PBM Practices
Drug Topics
APRIL 24, 2024
A Q&A with Douglas Hoey, CEO of NCPA, on ways to change the pharmacy payment model and deceptive practices being employed by PBMs.
Humana confirms 2024 guidance even as it beats the Street in Q1
Fierce Healthcare
APRIL 24, 2024
Humana posted $741 million in profit for the first quarter, surpassing Wall Street analysts' predictions. | Humana posted $741 million in profit for the first quarter, surpassing Wall Street analysts' predictions.
Short-Term CGM for T1D More Effective Than Self-Monitoring Blood Glucose
Drug Topics
APRIL 24, 2024
Researchers’ objective was to assess the short-term glycemic benefits of continuous glucose monitoring (CGM) systems compared with patients with type 1 diabetes (T1D) who self-monitor.
Biogen 'turning the corner' as Leqembi and Skyclarys launches advance, but much work remains to be done: CEO
Fierce Pharma
APRIL 24, 2024
While Biogen’s Chris Viehbacher figures the company is “turning the corner” after several recent setbacks—thanks in large part to accelerating launches of new drugs like Leqembi and Skyclarys—the C | While Biogen’s Chris Viehbacher figures the company is “turning the corner” after several recent setbacks, the CEO admitted Wednesday that there’s still “a lot of work to do” as the biotech plugs ahead with its “Fit for Growth” savings initiative.
Exploring Challenges, Opportunities for Community Pharmacists in Tobacco Cessation
Drug Topics
APRIL 24, 2024
By addressing integration barriers associated with implementing tobacco cessation programs in the community pharmacy, community pharmacists can “significantly impact public health by increasing access to effective cessation support,” wrote investigators.
Let's personalize your content